S2. Multivariate Cox regression analyses of risk factors for PFS before PSM.
Variables | HR (95% CI) | P |
PFS, progress-free survival; PSM, propensity score matching; T2DM, type 2 diabetes mellitus; HR, hazard ratio; 95% CI, 95% confidence interval. | ||
T2DM (Yes vs. No) | 1.396 (1.001−1.945 ) | 0.049 |
Ascites (Yes vs. No) | 1.590 (1.233−2.050) | <0.001 |
Gastrectomy | 0.148 | |
Proximal vs. Total | 0.845 (0.588−1.214) | 0.362 |
Distal vs. Total | 0.769 (0.586−1.008) | 0.057 |
Lymphadenectomy (D2/D2+ vs. others) | 0.522 (0.368−0.740) | <0.001 |
Radical resection (Yes vs. No) | 0.473 (0.334−0.670) | <0.001 |
Grade | 0.069 | |
G3−4vs. G1−2 | 0.990 (0.813−1.204) | 0.918 |
Unknown vs. G1−2 | 1.271 (0.979−1.649) | 0.071 |
Vascular invasion (Yes vs. No) | 1.078 (0.894−1.301) | 0.431 |
Primary tumor invasion | 0.001 | |
T2 vs. T1 | 2.123 (1.316−3.424) | 0.002 |
T3 vs. T1 | 2.720 (1.699−4.354) | <0.001 |
T4 vs. T1 | 3.332 (2.285−4.858) | <0.001 |
Lymph node status | <0.001 | |
N1 vs. N0 | 1.667 (1.284−2.164) | <0.001 |
N2 vs. N0 | 2.434 (1.917−3.091) | <0.001 |
N3 vs. N0 | 3.669 (2.914−4.619) | <0.001 |
Metastasis (M1 vs. M0) | 0.938 (0.642−1.371) | 0.742 |
Tumor size (cm) (≥5 vs. <5) | 0.834 (0.638−1.091) | 0.072 |